Bottom! Offering could be in preparation for this? Could be a opportunity? NFA just thinking outloud
$ENDRA Life Sciences (NDRA.US)$ Management believes that the meeting was highly informative and views the FDA's feedback as very constructive. Based on the feedback received as well as the Meeting Minutes expected in June, ENDRA will update its pivotal clinical study protocol and statistical plan for submission to the FDA as a next step prior to initiating the study.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
HotShot369 : mehehe i already entered low ;)
Trytosaveabit OP HotShot369 : Hehehe! Nicely done!
